Opicapone in Clinical Practice in Parkinson's UK Patients with Motor Fluctuations: Findings from the OPTIPARK Study

被引：0
|
作者：
Lees, A.
Reichmann, H. [1 ]
Magalhaes, D.
Rocha, J.
Soares-da-Silva, P. [2 ]
机构：
[1] Dept Neurol, Dresden, Germany
[2] BIAL Portela & Ca SA, Coronado, Portugal
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2021年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO-548
引用
收藏
页码：783 / 783
页数：1
相关论文
共 50 条
  • [41] Influence of disease duration in the Opicapone effectiveness in Parkinson's patients: real-world OPTIPARK study
    Warnecke, T.
    Reichmann, H.
    Lees, A.
    Marinho, D.
    Magalhaes, D.
    Rocha, J. F.
    Soares-da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 904 - 904
  • [42] Influence of demographic features in Opicapone effectiveness in Parkinson's patients: the real-world OPTIPARK study
    Mohamed, B.
    Lees, A.
    Reichmann, H.
    Martins, D.
    Magalhaes, D.
    Rocha, J. F.
    Soares-da-silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 903 - 903
  • [43] Effectiveness of opicapone in Parkinson's disease patients with motor fluctuations according to baseline use of monoamine-oxidase-B inhibitors (MAO-B) and dopamine agonists (DA): findings from the real-world OPTIPARK study
    Reichmann, H.
    Warnecke, T.
    Lees, A.
    Martins, D.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2021, 36 : S232 - S232
  • [44] Effect of opicapone and entacapone on daily pattern of motor fluctuations in Parkinson's disease patients
    Lees, A.
    Rascol, O.
    Ferreira, J.
    Klepitskaya, O.
    Fonseca, M.
    Magalhaes, D.
    Rocha, J. -F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2020, 35 : S461 - S461
  • [45] 1-year safety of opicapone in patients with Parkinson's disease and motor fluctuations
    Lees, A.
    Ferreira, J.
    Costa, R.
    Oliveira, C.
    Pinto, R.
    Lopes, N.
    Nunes, T.
    Rocha, J. F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2015, 30 : S99 - S99
  • [46] Opicapone's onset and stabilisation of treatment effects in Parkinson's disease patients with motor fluctuations
    Lees, A.
    Ferreira, J.
    Reichmann, H.
    Tolosa, E.
    Santos, A.
    Oliveira, C.
    Oliveira, I.
    Lopes, N.
    Rocha, J. F.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 651 - 651
  • [47] EFFICACY OF OPICAPONE IN DIFFERENT TREATMENT REGIMENS IN PARKINSON'S DISEASE PATIENTS WITH MOTOR FLUCTUATIONS
    Antonini, A.
    Ebersbach, G.
    Rascol, O.
    Ikedo, F.
    Magalhaes, D.
    Rocha, J. -F.
    Soares-da-Silva, P.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E64 - E65
  • [48] Efficacy of Opicapone and Levodopa with Different Levodopa Daily Doses in Parkinson's disease (PD) Patients with Early Motor Fluctuations: Findings from the Korean ADOPTION Study
    Lee, J.
    Ferreira, J.
    Ma, H.
    Rocha, J.
    Jeon, B.
    MOVEMENT DISORDERS, 2024, 39 : S310 - S311
  • [49] Effect of Opicapone and Levodopa on the Different Daily OFF Patterns in Patients with Parkinson's disease (PD) and Early Motor Fluctuations: Findings from the Korean ADOPTION Study
    Rocha, J.
    Lee, J.
    Ferreira, J.
    Ma, H.
    Jeon, B.
    MOVEMENT DISORDERS, 2024, 39 : S311 - S312
  • [50] Effectiveness of opicapone in Parkinson's disease patients with motor fluctuations according to baseline use of monoamine-oxidase-b inhibitors and dopamine agonists: The real-world OPTIPARK study
    Reichmann, Heinz
    Warnecke, Tobias
    Lees, Andrew
    Martins, Diogo
    Magalhaes, Diogo
    Rocha, Jose
    Soares-Da-Silva, Patricio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 272 - 273
12345